• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 and strongyloidiasis: what to expect from this coinfection?

作者信息

Pereira Carolina Victoria Marcitelli, Mastandrea Giovanna Ribeiro Achur, Medeiros Ana Clara Cassine de Souza, Gryschek Ronaldo Cesar Borges, Paula Fabiana Martins de, Corral Marcelo Andreetta

机构信息

Faculdade de Medicina, Universidade Santo Amaro, Sao Paulo, SP, BR.

Laboratorio de Investigacao Medica (LIM06-Laboratorio de Imunopatologia da Equistossomose), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR.

出版信息

Clinics (Sao Paulo). 2021 Nov 19;76:e3528. doi: 10.6061/clinics/2021/e3528. eCollection 2021.

DOI:10.6061/clinics/2021/e3528
PMID:34817048
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8579849/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9382/8579849/5e852eb38124/cln-76-e3528-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9382/8579849/5e852eb38124/cln-76-e3528-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9382/8579849/5e852eb38124/cln-76-e3528-g001.jpg

相似文献

1
COVID-19 and strongyloidiasis: what to expect from this coinfection?新型冠状病毒肺炎与类圆线虫病：这种合并感染会出现什么情况？
Clinics (Sao Paulo). 2021 Nov 19;76:e3528. doi: 10.6061/clinics/2021/e3528. eCollection 2021.
2
Strongyloidiasis: An Important Coinfection in the COVID-19 Era.类圆线虫病：新冠疫情时代一种重要的合并感染
Am J Trop Med Hyg. 2021 Sep 22;105(5):1134-1135. doi: 10.4269/ajtmh.21-0677.
3
Strongyloides in bronchoalveolar lavage fluid: practical implications in the COVID-19 era.支气管肺泡灌洗液中的类圆线虫：COVID-19 时代的实际意义。
J Travel Med. 2022 Jan 17;29(1). doi: 10.1093/jtm/taab114.
4
Screening for strongyloidiasis in Spain in the context of the SARS-CoV-2 pandemic: Results of a survey on diagnosis and treatment.西班牙在 SARS-CoV-2 大流行背景下的旋毛虫病筛查：诊断和治疗调查结果。
Enferm Infecc Microbiol Clin (Engl Ed). 2023 Jun-Jul;41(6):329-334. doi: 10.1016/j.eimce.2022.08.006. Epub 2022 Aug 12.
5
Reactivation of Strongyloides stercoralis in patients with SARS-CoV-2 pneumonia receiving dexamethasone.在接受地塞米松治疗的新冠病毒肺炎患者中粪类圆线虫的再激活
Med Clin (Barc). 2022 Mar 11;158(5):242-243. doi: 10.1016/j.medcli.2021.05.004. Epub 2021 May 27.
6
Coinfection with and in a COVID-19-positive male presenting with acute abdomen: a case report.COVID-19 阳性男性患者以急性腹痛为表现的 和 合并感染：一例病例报告。
Future Microbiol. 2022 Sep;17:1099-1105. doi: 10.2217/fmb-2022-0027. Epub 2022 Jul 28.
7
High prevalence of anti-Strongyloides antibody in SARS-CoV-2-infected human sera in a Thai hospital: Rapid serological screening.泰国某医院 SARS-CoV-2 感染患者血清中抗旋毛虫抗体的高流行率：快速血清学筛查。
J Infect Public Health. 2024 Aug;17(8):102466. doi: 10.1016/j.jiph.2024.05.054. Epub 2024 May 31.
8
Case Report: Disseminated Strongyloidiasis in a Patient with COVID-19.病例报告：COVID-19 患者合并播散性粪类圆线虫病。
Am J Trop Med Hyg. 2020 Oct;103(4):1590-1592. doi: 10.4269/ajtmh.20-0699.
9
Antimicrobial Management of Disseminated Strongyloidiasis in a COVID-19 Patient.一名新冠肺炎患者播散性类圆线虫病的抗菌治疗
Am J Trop Med Hyg. 2020 Nov;103(5):2150. doi: 10.4269/ajtmh.20-1059b.
10
Influence of the drugs used in migrant patients with severe acute respiratory syndrome coronavirus 2 and the development of symptomatic strongyloidiasis.在患有严重急性呼吸综合征冠状病毒 2 的移民患者中使用药物的影响和症状性蠕形住肠线虫病的发展。
Trans R Soc Trop Med Hyg. 2022 May 2;116(5):440-445. doi: 10.1093/trstmh/trab152.

引用本文的文献

1
Prevalence of asymptomatic strongyloidiasis co-infection in COVID-19 patients residing in endemic areas.流行地区 COVID-19 患者中无症状类圆线虫合并感染的发生率。
Eur J Med Res. 2023 Aug 11;28(1):281. doi: 10.1186/s40001-023-01262-9.
2
From past to present: opportunities and trends in the molecular detection and diagnosis of Strongyloides stercoralis.从过去到现在：粪类圆线虫分子检测和诊断的机会和趋势。
Parasit Vectors. 2023 Apr 11;16(1):123. doi: 10.1186/s13071-023-05763-8.
3
Strongyloides and COVID-19: Challenges and Opportunities for Future Research.

本文引用的文献

1
Reactivation of in patients with SARS-CoV-2 pneumonia receiving dexamethasone.接受地塞米松治疗的新型冠状病毒肺炎患者中[具体内容缺失]的重新激活。
Med Clin (Engl Ed). 2022 Mar 11;158(5):242-243. doi: 10.1016/j.medcle.2021.05.011. Epub 2022 Jan 14.
2
Eosinophilia and abdominal pain after severe pneumonia due to COVID 19.新型冠状病毒肺炎（COVID-19）所致重症肺炎后的嗜酸性粒细胞增多和腹痛
Enferm Infecc Microbiol Clin (Engl Ed). 2021 Nov;39(9):478-480. doi: 10.1016/j.eimce.2021.08.007. Epub 2021 Aug 24.
3
Diagnosis of human strongyloidiasis: Application in clinical practice.
类圆线虫与新型冠状病毒肺炎：未来研究的挑战与机遇
Trop Med Infect Dis. 2023 Feb 19;8(2):127. doi: 10.3390/tropicalmed8020127.
4
: A Neglected but Fatal Parasite.一种被忽视却致命的寄生虫。
Trop Med Infect Dis. 2022 Oct 17;7(10):310. doi: 10.3390/tropicalmed7100310.
5
Evaluation of Strongyloides Awareness and Knowledge among Canadian Physicians Caring for Patients At Risk for Severe Strongyloidiasis: A National Cross-sectional Survey.评估加拿大照顾重症感染风险患者的医生对旋毛虫病的认识和知识：一项全国性横断面调查。
Am J Trop Med Hyg. 2022 Jul 5;107(2):359-366. doi: 10.4269/ajtmh.22-0109. Print 2022 Aug 17.
6
Strongyloides Hyperinfection Syndrome among COVID-19 Patients Treated with Corticosteroids.COVID-19 患者接受皮质类固醇治疗后的旋毛虫过度感染综合征。
Emerg Infect Dis. 2022 Jul;28(7):1531-1533. doi: 10.3201/eid2807.220198.
7
Scientific legacy of COVID-19 at the FMUSP-HC academic health system: current status and implications for the future.圣保罗大学医学院-医院学术健康系统中新冠疫情的科学遗产：现状与未来启示
Clinics (Sao Paulo). 2021 Dec 8;76:e3630. doi: 10.6061/clinics/2021/e3630. eCollection 2021.
人鞭虫病的诊断：临床应用。
Acta Trop. 2021 Nov;223:106081. doi: 10.1016/j.actatropica.2021.106081. Epub 2021 Aug 5.
4
Corticosteroids in Covid-19 pandemic have the potential to unearth hidden burden of strongyloidiasis.新冠疫情中使用的皮质类固醇有可能揭示类圆线虫病的潜在负担。
IDCases. 2021;25:e01192. doi: 10.1016/j.idcr.2021.e01192. Epub 2021 Jun 12.
5
Dexamethasone and COVID-19: Strategies in Low- and Middle-Income Countries to Tackle Steroid-Related Strongyloides Hyperinfection.地塞米松与 COVID-19：中低收入国家应对类固醇相关强虫性感染的策略。
Am J Trop Med Hyg. 2021 Mar 15;104(5):1611-1612. doi: 10.4269/ajtmh.20-1085.
6
Risk of Strongyloides Hyperinfection Syndrome when prescribing dexamethasone in severe COVID-19.在重症新型冠状病毒肺炎（COVID-19）患者中开具地塞米松处方时发生类圆线虫超感染综合征的风险。
Travel Med Infect Dis. 2021 Mar-Apr;40:101981. doi: 10.1016/j.tmaid.2021.101981. Epub 2021 Jan 31.
7
Ivermectin: an award-winning drug with expected antiviral activity against COVID-19.伊维菌素：一种具有抗 COVID-19 预期抗病毒活性的获奖药物。
J Control Release. 2021 Jan 10;329:758-761. doi: 10.1016/j.jconrel.2020.10.009. Epub 2020 Oct 7.
8
Neglected tropical diseases in non-endemic countries in the era of COVID-19 pandemic: the great forgotten.在 COVID-19 大流行时代的非流行国家中的被忽视热带病：被严重遗忘的疾病。
J Travel Med. 2021 Jan 6;28(1). doi: 10.1093/jtm/taaa179.
9
Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia.严重的新冠肺炎感染患者在接受免疫抑制治疗后出现了旋毛虫感染。
Infection. 2021 Jun;49(3):539-542. doi: 10.1007/s15010-020-01522-4. Epub 2020 Sep 10.
10
Case Report: Disseminated Strongyloidiasis in a Patient with COVID-19.病例报告：COVID-19 患者合并播散性粪类圆线虫病。
Am J Trop Med Hyg. 2020 Oct;103(4):1590-1592. doi: 10.4269/ajtmh.20-0699.